MOVIMENTO PARADOSSO DEL SETTO INTERVENTRICOLARE ED EAS IN UN CASO DI CARDIOPATA CONGENITA COMPLESSA DELL' ADULTO A PREVALENTE SEVRACCARICO DI PRESSIONE DEL VENTRICOLO DESTRO = MOUVEMENT PARADOXAL DE LA CLOISON INTERVENTRICULAIRE ET DEVIATION GAUCHE DE L'AXE DANS UN CAS DE CARDIOPATHIE CONGENITALE COMPLEXE DE L'ADULTE AVEC SURCHARGE PREDOMINANTE DE PRESSION DU VENTRICULE DROITD'ANNUNZIO E; MOBILIJ A; OLIVIERI N et al.1982; MINERVA MED.; ISSN 0026-4806; ITA; DA. 1982; VOL. 73; NO 14; PP. 817-820; ABS. ENG; BIBL. 4 REF.Article

Reactivation of fetal hemoglobin in patients with β-thalassemiaOLIVIERI, N. F.Seminars in hematology. 1996, Vol 33, Num 1, pp 24-42, issn 0037-1963Article

Iron overload cardiomyopathies : new insights into an old diseaseLIU, P; OLIVIERI, N.Cardiovascular drugs and therapy. 1994, Vol 8, Num 1, pp 101-110, issn 0920-3206Article

Long-term therapy with deferiproneOLIVIERI, N. F.Acta haematologica. 1996, Vol 95, Num 1, pp 37-48, issn 0001-5792Article

Orally active iron chelatorsMERSON, L; OLIVIERI, N.Blood reviews. 2002, Vol 16, Num 2, pp 127-134, issn 0268-960XArticle

The therapeutic reactivation of fetal haemoglobinOLIVIERI, N. F; WEATHERALL, D. J.Human molecular genetics (Print). 1998, Vol 7, Num 10, pp 1655-1658, issn 0964-6906Article

Hydroxyurea in children with sickle cell disease : Impact on splenic function and compliance with therapyOLIVIERI, N. F; VICHINSKY, E. P.Journal of pediatric hematology/oncology. 1998, Vol 20, Num 1, pp 26-31, issn 1077-4114Article

Compliance assessed by the medication event monitoring systemOLIVIERI, N. F; MATSUI, D; HERMANN, C et al.Archives of disease in childhood. 1991, Vol 66, Num 12, pp 1399-1402, issn 0003-9888Article

Use of a eutectic mixture of local anesthetics for prolonged subcutaneous drug administrationBERKOVITCH, M; DAVIS, S; MATSUI, D et al.Journal of clinical pharmacology. 1995, Vol 35, Num 3, pp 295-297, issn 0091-2700Article

Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular ironRANDELL, E. W; PARKES, J. G; OLIVIERI, N. F et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 23, pp 16046-16053, issn 0021-9258Article

Clinical use of the medication event monitoring system : a new window into pediatric complianceMATSUI, D; HERMANN, C; BRAUDO, M et al.Clinical pharmacology and therapeutics. 1992, Vol 52, Num 1, pp 102-103, issn 0009-9236Article

Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell diseaseBERKOVITCH, M; PAPADOURIS, D; SHAW, D et al.British journal of clinical pharmacology. 1998, Vol 45, Num 6, pp 605-607, issn 0306-5251Article

The pharmacokinetics and pharmacodynamics of the oral iron chelator deferiprone (L1) in relation to hemoglobin levelsFASSOS, F. F; KLEIN, J; FERNANDES, D et al.International journal of clinical pharmacology and therapeutics. 1996, Vol 34, Num 7, pp 288-292, issn 0946-1965Article

Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelatorMATSUI, D; HERMANN, C; KLEIN, J et al.Journal of clinical pharmacology. 1994, Vol 34, Num 9, pp 944-949, issn 0091-2700Article

Urinary iron excretion depends on the mode of administration of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with homozygous β-thalassemiaFASSOS, F. F; KLEIN, J; FERNANDES, D et al.Clinical pharmacology and therapeutics. 1994, Vol 55, Num 1, pp 70-75, issn 0009-9236Article

Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cellsPARKES, J. G; HUSSAIN, R. A; OLIVIERI, N. F et al.The Journal of laboratory and clinical medicine. 1993, Vol 122, Num 1, pp 36-47, issn 0022-2143Article

Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicityBENTUR, Y; KOREN, G; TESORO, A et al.Clinical pharmacology and therapeutics. 1990, Vol 47, Num 4, pp 478-482, issn 0009-9236Conference Paper

Infection due to yersinia enterocolitica in a series of patients with β-thalassemia : Incidence and predisposing factors. Editorial responseADAMKIEWICZ, T. V; BERKOVITCH, M; KRISHNAN, C et al.Clinical infectious diseases. 1998, Vol 27, Num 6, pp 1362-1368, issn 1058-4838Article

Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patientsOLIVIERI, N. F; KOREN, G; HERMANN, C et al.Lancet (British edition). 1990, Vol 336, Num 8726, pp 1275-1279, issn 0140-6736, 5 p.Article

Expression of SCL is normal in transfusion-dependent Diamond-Blackfan anemia but other bHLH proteins are deficientZHANG, M.-Y; CLAWSON, G. A; OLIVIERI, N. F et al.Blood. 1997, Vol 90, Num 5, pp 2068-2074, issn 0006-4971Article

Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinapathiesSHER, G. D; GINDER, G. D; LITTLE, J et al.The New England journal of medicine. 1995, Vol 332, Num 24, pp 1606-1610, issn 0028-4793Article

Reduction in tissue iron stores with a new regimen of continuous ambulatory intravenous deferoxamineOLIVIERI, N. F; BERRIMAN, A. M; TYLER, B. J et al.American journal of hematology. 1992, Vol 41, Num 1, pp 61-63, issn 0361-8609Article

A new frameshift β^°-thalassemia mutation (codons 27-28 + C) found in a chinese familySHIPING CAI; CHUI, D. H. K; NG, J et al.American journal of hematology. 1991, Vol 37, Num 1, pp 6-8, issn 0361-8609Article

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia majorWOLFE, L; OLIVIERI, N; SALLAN, D et al.The New England journal of medicine. 1985, Vol 312, Num 25, pp 1600-1603, issn 0028-4793Article

Page / 3